Rustgi AK, El-Serag HB. Esophageal carcinoma. N Engl J Med. 2014;371(26):2499-509. doi:10.1056/NEJMra1314530.
Lundell LR. Etiology and risk factors for esophageal carcinoma. Dig Dis. 2010;28(4-5):641-4. doi:10.1159/000320452.
Hamel C, Ahmadzai N, Beck A, Thuku M, Skidmore B, Pussegoda K et al. Screening for esophageal adenocarcinoma and precancerous conditions (dysplasia and Barrett's esophagus) in patients with chronic gastroesophageal reflux disease with or without other risk factors: two systematic reviews and one overview of reviews to inform a guideline of the Canadian Task Force on Preventive Health Care (CTFPHC). Systematic reviews. 2020;9(1):20. doi:10.1186/s13643-020-1275-2.
Hur C, Miller M, Kong CY, Dowling EC, Nattinger KJ, Dunn M et al. Trends in esophageal adenocarcinoma incidence and mortality. Cancer. 2013;119(6):1149-58. doi:10.1002/cncr.27834.
Njei B, McCarty TR, Birk JW. Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis. J Gastroenterol Hepatol. 2016;31(6):1141-6. doi:10.1111/jgh.13289.
Ilson DH. Adenocarcinoma of the esophagus: controversies and consensus. Chinese clinical oncology. 2017;6(5):52. doi:10.21037/cco.2017.09.02.
van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074-84. doi:10.1056/NEJMoa1112088.
Shapiro J, van Lanschot JJB, Hulshof M, van Hagen P, van Berge Henegouwen MI, Wijnhoven BPL et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;16(9):1090-8. doi:10.1016/s1470-2045(15)00040-6.
Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345(10):725-30. doi:10.1056/NEJMoa010187.
Hulscher JB, van Sandick JW, de Boer AG, Wijnhoven BP, Tijssen JG, Fockens P et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347(21):1662-9. doi:10.1056/NEJMoa022343.
Sihag S, Kosinski AS, Gaissert HA, Wright CD, Schipper PH. Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Comparison of Early Surgical Outcomes From The Society of Thoracic Surgeons National Database. Ann Thorac Surg. 2016;101(4):1281-8; discussion 8-9. doi:10.1016/j.athoracsur.2015.09.095.
Biere SS, van Berge Henegouwen MI, Maas KW, Bonavina L, Rosman C, Garcia JR et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet. 2012;379(9829):1887-92. doi:10.1016/s0140-6736(12)60516-9.
Mariette C, Markar SR, Dabakuyo-Yonli TS, Meunier B, Pezet D, Collet D et al. Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer. N Engl J Med. 2019;380(2):152-62. doi:10.1056/NEJMoa1805101.
Luketich JD, Pennathur A, Franchetti Y, Catalano PJ, Swanson S, Sugarbaker DJ et al. Minimally invasive esophagectomy: results of a prospective phase II multicenter trial-the eastern cooperative oncology group (E2202) study. Ann Surg. 2015;261(4):702-7. doi:10.1097/sla.0000000000000993.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205-13. doi:10.1097/01.sla.0000133083.54934.ae.
Slankamenac K, Graf R, Barkun J, Puhan MA, Clavien PA. The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg. 2013;258(1):1-7. doi:10.1097/SLA.0b013e318296c732.
Katayama H, Kurokawa Y, Nakamura K, Ito H, Kanemitsu Y, Masuda N et al. Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria. Surg Today. 2016;46(6):668-85. doi:10.1007/s00595-015-1236-x.
Meredith KL, Maramara T, Blinn P, Lee D, Huston J, Shridhar R. Comparative Perioperative Outcomes by Esophagectomy Surgical Technique. J Gastrointest Surg. 2019. doi:10.1007/s11605-019-04269-y.
Metcalfe C, Avery K, Berrisford R, Barham P, Noble SM, Fernandez AM et al. Comparing open and minimally invasive surgical procedures for oesophagectomy in the treatment of cancer: the ROMIO (Randomised Oesophagectomy: Minimally Invasive or Open) feasibility study and pilot trial. Health Technol Assess. 2016;20(48):1-68. doi:10.3310/hta20480.
van Workum F, Bouwense SA, Luyer MD, Nieuwenhuijzen GA, van der Peet DL, Daams F et al. Intrathoracic versus Cervical ANastomosis after minimally invasive esophagectomy for esophageal cancer: study protocol of the ICAN randomized controlled trial. Trials. 2016;17(1):505. doi:10.1186/s13063-016-1636-2.
Kataoka K, Takeuchi H, Mizusawa J, Ando M, Tsubosa Y, Koyanagi K et al. A randomized Phase III trial of thoracoscopic versus open esophagectomy for thoracic esophageal cancer: Japan Clinical Oncology Group Study JCOG1409. Jpn J Clin Oncol. 2016;46(2):174-7. doi:10.1093/jjco/hyv178.
van der Sluis PC, van der Horst S, May AM, Schippers C, Brosens LAA, Joore HCA et al. Robot-assisted Minimally Invasive Thoracolaparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy for Resectable Esophageal Cancer: A Randomized Controlled Trial. Ann Surg. 2019;269(4):621-30. doi:10.1097/sla.0000000000003031.
Guo W, Ma X, Yang S, Zhu X, Qin W, Xiang J et al. Combined thoracoscopic-laparoscopic esophagectomy versus open esophagectomy: a meta-analysis of outcomes. Surg Endosc. 2016;30(9):3873-81. doi:10.1007/s00464-015-4692-x.
Nagpal K, Ahmed K, Vats A, Yakoub D, James D, Ashrafian H et al. Is minimally invasive surgery beneficial in the management of esophageal cancer? A meta-analysis. Surg Endosc. 2010;24(7):1621-9. doi:10.1007/s00464-009-0822-7.
Espinoza-Mercado F, Imai TA, Borgella JD, Sarkissian A, Serna-Gallegos D, Alban RF et al. Does the Approach Matter? Comparing Survival in Robotic, Minimally Invasive, and Open Esophagectomies. Ann Thorac Surg. 2019;107(2):378-85. doi:10.1016/j.athoracsur.2018.08.039.
Markar SR, Ni M, Gisbertz SS, van der Werf L, Straatman J, van der Peet D et al. Implementation of Minimally Invasive Esophagectomy From a Randomized Controlled Trial Setting to National Practice. J Clin Oncol. 2020:Jco1902483. doi:10.1200/jco.19.02483.
Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346(15):1128-37. doi:10.1056/NEJMsa012337.
Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA. 1998;280(20):1747-51. doi:10.1001/jama.280.20.1747.
Killeen SD, O'Sullivan MJ, Coffey JC, Kirwan WO, Redmond HP. Provider volume and outcomes for oncological procedures. Br J Surg. 2005;92(4):389-402. doi:10.1002/bjs.4954.
Birkmeyer JD, Sun Y, Wong SL, Stukel TA. Hospital volume and late survival after cancer surgery. Ann Surg. 2007;245(5):777-83. doi:10.1097/01.sla.0000252402.33814.dd.
Koëter M, van der Sangen MJ, Hurkmans CW, Luyer MD, Rutten HJ, Nieuwenhuijzen GA. Radiation dose does not influence anastomotic complications in patients with esophageal cancer treated with neoadjuvant chemoradiation and transhiatal esophagectomy. Radiat Oncol. 2015;10:59. doi:10.1186/s13014-015-0361-4.
Vande Walle C, Ceelen WP, Boterberg T, Vande Putte D, Van Nieuwenhove Y, Varin O et al. Anastomotic complications after Ivor Lewis esophagectomy in patients treated with neoadjuvant chemoradiation are related to radiation dose to the gastric fundus. Int J Radiat Oncol Biol Phys. 2012;82(3):e513-9. doi:10.1016/j.ijrobp.2011.05.071.